Aim: Insulin exerts anti-apoptotic effects in both cardiomyocytes and coronary endothelial cells following ischemia/reperfusion (I/R) via the Akt-endothelial nitric oxide synthase survival signal pathway. This important insulin signaling might further contribute to the improvement of cardiac function after reperfusion.
Introduction
Our previous study showed that in vivo treatment with insulin reduced postischemic apoptotic death in both cardiomyocytes and coronary endothelial cells by activating the phosphatidylinositol 3-kinase-Akt-endothelial nitric oxide synthase (PI3-kinase-Akt-eNOS) pathway, that is, the survival signaling pathway, which might further contribute to the prolonged improvement of cardiac performance following ischemia/reperfusion (I/R) [1] [2] [3] . In a recent study, we have demonstrated that insulin exerts direct positive inotropic effect by increasing calcium (Ca 2+ ) transients in I/R cardiomyocytes. This insulin-induced improvement of contractile function in I/R myocytes shares the same signaling cascade for protection as previously described for myocardial tissue [4] . These observations therefore indicate that this survival pathway is also active to directly improve cardiac myocyte function recovery following I/R in vitro experiments that guarantee constant conditions and exclude other factors, such as stress, hormone secretion, or inflamatory mediators, rendering insulin even more important as a protective agent applicable to reperfused myocardial tissue. However, the mechanisms underlying the insulin-induced improvement of I/R myocyte functional recovery through activation of the survival pathway in vitro remain largely elusive.
Cardiac contraction and relaxation are closely regulated by intrinsic machineries governing sequential rise and fall of cytosolic Ca 2+ . Ca 2+ enters the cytosolic space through voltage-dependent Ca 2+ channels after membrane depolarization and triggers release of Ca 2+ from sarcoplasmic reticulum (SR), which initiates activation of cardiac contractile proteins and actin-myosin cross-bridge linking. Termination of contraction and cardiac relaxation are initiated with the removal of cytosolic Ca 2+ mainly through sarcoplasmic reticulum Ca 2+ -ATPase (SERCA) and, to a lesser extent, Na + -Ca 2+ exchanger. It was shown that in rat ventricular myocardium, 92% of calcium removal occurs by SR calcium uptake [5] . SERCA2a, the isoform of SERCA in myocardium and slow twitch skeletal muscle, is responsible for not only Ca 2+ extrusion but also ventricular contractility because of their role in Ca 2+ extrusion and SR Ca 2+ loading for the next cardiac cycle [5, 6] . Defects in SERCA2a lead to decreased peak myocyte contractility, reduced intracellular Ca 2+ removal, and prolonged duration of the cardiac cycle. Heart failure (HF) is a common outcome of myocardial infarction (MI) and is associated with a poor prognosis. Because of the loss of contractile function in the infarcted area, MI results in increased mechanical load on the intact myocardium, which undergoes molecular, cellular, morphological, and functional remodeling. Decreased SR Ca 2+ uptake and decreased expression of SERCA2a are key features of cardiac myocyte dysfunction in both experimental and human HF [7, 8] . Hypertrophic cardiomyocytes with reduced contractility and relaxation have been found in the failing rat heart after MI, accompanied by a reduced peak in Ca 2+ transients and prolonged Ca 2+ transients decay [9] . SERCA mRNA and protein levels decreased with increasing severity of HF after left coronary artery ligation [7] . Indeed, in cardiomyocytes isolated from the left ventricle of patients with end-stage HF, SERCA2a overexpression can restore normal Ca 2+ cycling [6] . Previous studies in adult myocytes isolated from rat hearts 3 weeks after MI demonstrated abnormal contractility, intracellular Ca 2+ concentration ([Ca   2+ ] i ) homeostasis and decreased SERCA2a expression and activity [10] . However, no data are available so far on the effect of insulin on SERCA2a activity in I/R cardiomyocytes.
Last, but not least, activation of Akt and its upstream signal PI3-kinase might dramatically improve cardiac function and protect against apoptosis [1, 2, 4] , establishing an important role for Akt in the maintenance of heart morphology and function. Transgenic overexpression of protein kinase Akt enhances myocyte contractility and relaxation through acceleration of intracellular Ca 2+ transients. The underlying cellular mechanism(s) include potentiation of L-type Ca 2+ channel function and upregulation of SERCA2a [11] . However, to date, a direct link between the effects of insulin on SERCA2a activity in I/R myocardium and the insulin-induced survival pathway and subsequent improvement of I/R myocyte functional recovery has not been established.
The aims of this study, therefore, were to determine the role of SERCA2a in the insulin-induced improvement of I/R cardiomyocyte functional recovery, and to further investigate the mechanism involved.
Materials and methods

Preparation of isolated cardiomyocytes
The experiments were carried out in adherence with the National Institutes of Health Guidelines on the Use of Laboratory Animals and were approved by the Fourth Military Medical University Committee on Animal Care. Calcium-tolerant ventricular myocytes were isolated from adult male Sprague-Dawley rats (body weight, 220-250 g) hearts by a standard enzymatic technique [4] . Briefly, rats were anesthetized and anticoagulated with heparin sodium (1000 U/kg, ip). The hearts were rapidly excised and mounted on a Langendorff perfusion apparatus, and immediately perfused with Ca Measurement of myocyte contractile and relaxation function The mechanical contraction of ventricular myocytes was assessed by a video-based motion edge-detection system (IonOptix, Milton, USA) [12] . In brief, myocytes were transferred to a cell chamber on the stage of an inverted microscope (Olympus, Tokyo, Japan) and continuously perfused with Tyrode's solution (1 mL/min, 35 °C). Myocyte contraction was induced at a frequency of 0.5 Hz by platinum electrodes connected to an electrical stimulator. Peak twitch amplitude (PTA), time to peak shortening (TPS), time to 70% relengthening (TR70), and the maximal velocities of shortening/relengthening (±dL/dt) were automatically calculated from the cell length data by a computer. Criteria for choosing myocytes for the experiment included: (1) a rod shape with clear edges; (2) clearly defined sarcomeric striations; (3) steady contraction in response to electrical stimulation but without spontaneous contractions; and (4) stable steady-state contraction amplitude for at least 5 min before drugs were given.
Measurement of myocyte Ca 2+ transients Myocytes were loaded with Fura-2/AM (0.5 µmol/L; Alexis Biochemicals, San Diego, USA) for 30 min. The myocytes were excited by light emitted by a 75 W lamp and passed through either a 360 or 380 nm filter, and the Fura emission wavelength (510 nm) was synchronously monitored. Intracellular free Ca 2+ in loaded myocytes was measured as the fluorescence ratio (360/380 nm) [4] . Experimental protocols Ischemia conditions were simulated by chemical anoxia solution according to the method described by Esumi et al [13] , which contained (in mmol/L): 137.0 NaCl, 15.8 KCl, 0.49 MgCl 2 , 0.9 CaCl 2 ·2H 2 O, 4.0 HEPES, 10.0 deoxyglucose, 0.75 sodium dithionate and 20.0 lactate, pH 6.5. Ventricular myocytes from rats were perfused with Tyrode's solution and field stimulated at a frequency of 0.5 Hz, 5 ms duration. After 10-15 min of equilibration, the myocytes were exposed to one of the following treatments (15-20 myocytes from 6-8 rats/group): (1) control (Con), myocytes were perfused with Tyrode's solution for 45 min; (2) control plus insulin (Con+Ins), myocytes were perfused with 10 -7 mol/L insulin for 45 min; (3) (I/R), after ischemia was simulated by perfusion of myocytes with chemical anoxia solution for 15 min, the cells were reperfused with Tyrode's solution for 30 min; (4) I/R plus insulin (I/R+Ins), after undergoing the same ischemia procedure as the I/R group, the cardiomyocytes were reperfused with insulin for 30 min; (5) I/R plus insulin plus Akt inhibitor (I/R+Ins+AI), the isolated myocytes were subjected to the same I/R procedure as the I/R plus insulin group, and pretreated with a selective Akt inhibitor, AI (1L-6-Hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate, 5.0 µmol/L; Calbiochem, Darmstadt, Germany) [14, 15] for 2 h before the I/R procedure and were treated with AI in the same concentration throughout the whole I/R duration. Myocyte shortening and intracellular Ca 2+ transients were assessed as described above. Western blot analysis To determine the mechanism of the protective effect of insulin on I/R cardiomyocytes, an additional experiment was carried out to examine Akt expression and activation by Western blot analysis as described [1] . Isolated cells were randomly divided into 5 groups to receive the treatments according to the experimental protocols. Ventricular myocytes were washed with phosphate-buffered saline and centrifuged at 1000×g. Cells were collected, washed and homogenized in lysis buffer containing (in mmol/L) 20.0 Tris, 150.0 NaCl, 1.0 EDTA, 1.0 EGTA, 1% Triton X-100, 2.5 sodium pyrophosphate, 1.0 β-glycerolphosphate, 1.0 Na 3 VO 4 , 1.0 g/L leupeptin, and 1.0 phenylmethylsulphonyl fluoride (pH 7.5). After sonication, the lysate was centrifuged at 4 °C (12 000×g, 10 min). The protein of the lysate was quantified and separated by sodium dodecylsulfatepolyacrylamide gel electrophoresis and transferred onto a polyvinylidene difluoride-plus membrane. After being blocked with 5% milk, the immunoblots were probed with anti-pAkt (1:1000) antibodies overnight at 4 °C, followed by incubation with the corresponding secondary antibodies at room temperature for 1 h. The blots were visualized with ECL-plus reagent (Amersham Pharmacia Biotech, USA). pAkt immunoblots were then stripped with stripping buffer at 50 °C for 30 min and reblotted for total Akt (1:1000). AntiAkt and anti-pAkt antibodies (#9272 and #9271, respectively) were obtained from Cell Signaling Technology (Beverly, USA).
Preparation of SR from rat heart SR was prepared according to the methods of Jones as modified by Kodavanti et al [16] [17] [18] . The myocytes were put in homogenizing medium, containing (in mmol/L) 50.0 Na 2 HPO 4 , 10.0 Na 2 EDTA, and 25.0 NaF (pH 7.4). The minced ventricle tissue was placed in 10 mL of ice-cold homogenizing medium and homogenated 3 times. An additional 5 mL of homogenizing medium was added and the homogenate was sedimented twice for 20 min at 14 000×g at 4 °C. The supernatant was recentrifuged at 45 000×g for 30 min. The pellet obtained after this centrifugation, consisting of crude membrane vesicles (SR), was suspended in storage buffer containing (in mmol/L) 30.0 histidine, 0.25 mol/L sucrose, 10.0 EDTA, and 10.0 NaF (pH 7.4) to a final concentration of 30-40 mg/mL protein and stored at -80 °C until used.
Measurement of Ca
2+
-ATPase activity The activity of Ca 2+ -ATPase was determined with a kit (Jiancheng, Nanjing, China) by measuring the inorganic phosphate (Pi) liberated from ATP hydrolysis [17] . Ca [18] . Cardiac SR membranes were added to the reaction mixture at a final concentration of 20-25 µg of protein per milliliter, preincubated for 10 min at 37 °C and the reaction was initiated by the addition of ATP. The ATP hydrolysis that occurred in the absence of Ca 2+ (1 mmol/L EGTA) was subtracted to determine the activity of Ca 2+ -stimulated ATPase. Ouabain was added fresh to a final concentration of 1 mmol/L in the media, which remained unchanged throughout the incubation. Mitochondrial contamination was assessed by determining the activity of azide-sensitive ATPase, that is, that activity inhibited by 5 mmol/L sodium azide [19] .
Statistical analysis
All values in text, tables and figures are presented as mean±SEM. Differences were compared by Student's t-test or ANOVA, where appropriate. Probabilities of <0.05 were considered to be statistically significant. All of the statistical tests were carried out with GraphPad Prism software version 4.0 (GraphPad Software, San Diego, USA).
Results
Insulin improved cardiomyocyte contractile functional recovery in simulated I/R A simulated I/R model of myocytes was developed according to Esumi et al [13] , and the changes in cell contractile activity and intracellular Ca 2+ transients during I/R were determined. Ventricular myocytes were perfused with Tyrode's solution for 10-15 min while the field was stimulated at a frequency of 0.5 Hz, 5 ms duration. Following this equilibration period the myocytes were exposed to chemical anoxia solution for 15 min. PTA of myocytes undergoing ischemia was gradually decreased to 38%±8% of the pre-ischemic level (P<0.01, n=20 myocytes from 8 hearts). On commencement of reperfusion, PTA rapidly returned to near or transiently above pre-ischemia, then gradually declined to 87%±10% of the pre-ischemic level (P>0.05) with continued reperfusion ( Figure 1A) . Consistent with the contractile amplitude, ±dL/dt also had similar changes under conditions of simulated I/R ( Figure 1B) .
Insulin (10 -7 mol/L, the concentration used in most in vitro studies) [20, 21] exerted significant inotropic action in normal myocytes (21.8%±0.5% of Con+Ins group vs 17.9%± 0.8% of Con group; P<0.05, n=20 myocytes from 8 hearts) ( Table 1) . Although the contractile function of simulated I/R myocytes (underdoing ischemia for 15 min and reperfusion with Tyrode's solution for 30 min) could not completely recover to the level of the control group, in which the cells were perfused with Tyrode's solution for 45 min, there was no significant difference in contraction of the cells in the two groups (17.9%±0.8% of Con group vs 14.5%±0.7% of I/R group; P>0.05, n=20 myocytes from 8 hearts). However, consistent with our previous results, treatment with insulin at the beginning of reperfusion increased myocyte shortening in a concentration-dependent manner [4] . As summarized in Table 1 , insulin (10 -7 mol/L) significantly increased PTA (% baseline) and ±dL/dt, and markedly reduced time to peak shortening (TPS) and time to 70% relengthening (TR70) (20 myocytes from 7 rats, P<0.05 vs I/R group). The insulininduced effect on myocyte shortening appeared rapidly with the maximal response, which occurred within 5 min of exposure to insulin, and cells recovered almost completely after washout. These data showed that insulin improved cardiomyocyte contractile functional recovery in simulated I/R.
Insulin increased intracellular calcium transients in simulated I/R cardiomyocytes The time-course of the fluo- (Figure 2) . Consistent with our previous results, insulin significantly increased the calcium transients amplitude in normal myocytes (0.39±0.03 of Con+Ins group vs 0.35±0.04 of Con group, P<0.05, n=20 myocytes from 8 hearts) (Table 2) . Although vehicle reperfusion had no effect on the intracellular Ca 2+ transients, it was observed that insulin treatment at the onset of reperfusion significantly enhanced the ∆FFI from 0.32±0.03 of the I/R group to 0.36±0.04 (P<0.05) 5 min after reperfusion with insulin. Significantly shorter TTPCa and T 50 DCa were seen after exposure to insulin in I/R myocytes (both P<0.05), whereas the diastolic Ca 2+ level (resting FFI) had no significant change compared with the Con or I/R groups ( Table 2 ). These data suggested that there was enhanced Ca 2+ handling elicited by insulin in I/R myocytes. Mechanisms involved in improvement of contractile function Defects in SERCA2a lead to decreased peak myocyte contractility, reduced intracellular Ca 2+ removal, and prolonged duration of the cardiac cycle [10] . To study whether SERCA2a is also involved in the insulin-induced improvement of contractile function following I/R, the present study examined Ca 2+ -ATPase activity by an optical assay in crude SR extracted from control and simulated I/R myocytes. As shown in Figure 3 , insulin increased the SR Ca
2+
-ATPase activity in normal myocytes. It was seen that the SR Ca 2+ -ATPase activity was significantly decreased at the end of ischemia, whereas the vehicle reperfusion almost recovered the SR Ca A previous study demonstrated that transgenic overexpression of Akt increases myocyte contractility through acceleration of intracellular Ca 2+ transients [11] . To study the role of Akt in the insulin-induced positive inotropic effects on I/R myocytes, an additional experiment was carried out to determine the insulin-induced Akt activation in isolated cardiomyocytes by Western blot. As shown in Figure 4 , insulin markedly activated Akt activity in normal myocytes. Although the I/R procedure made no change in Akt activation, treatment with insulin resulted in a 2.9-fold increase in Akt phosphorylation (n=5, P<0.01 vs I/R group). There was no difference in total Akt among the groups studied (Figure 4) . These results showed that the insulin-induced inotropic effect on I/R myocytes might be, at least in part, Akt-dependent.
To further establish a cause-effect relationship between increased SERCA2a activity and the improved contractile response to insulin in simulated I/R myocytes through Akt activation, we pre-treated the myocytes with a selective AI (5.0 µmol/L) before insulin stimulation and assessed the changes in SERCA2a activity and myocyte contractile function. Pre-treatment with AI not only markedly decreased the Akt phosphorylation by insulin (P<0.01 vs I/R plus insulin group, Figure 4 ), but also inhibited the augmentation of SERCA2a activity in the insulin-treated I/R myocytes (n=8, P<0.05, Figure 3 ). In addition, AI treatment also almost completely abolished the contractile effect and the augmented intracellular calcium transients induced by insulin synchronously, whereas the same concentration of AI alone had no effect on either myocyte contraction or calcium transients (Tables 1,2 ). Previous studies and our preliminary experiment showed that AI, at the concentration of 5.0 µmol/L, selectively blocked Akt phosphorylation induced by insulin but did not affect PI-3 kinase activity [22, 23] . These results provided direct evidence demonstrating that increased SERCA2a activity, which is at least partly by enhanced Akt activation, plays a critical role in cardiac contractile response to insulin in I/R myocytes.
Discussion
In the present study we have demonstrated, for the first time, that insulin increases the SERCA2a activity and subsequently improves functional recovery in simulated I/R myocytes. This enhancement of SERCA2a activity by insu- lin is at least partly due to Akt activation. This finding suggests that insulin plays a more important role in the cardioprotection of ischemic/reperfused myocardium by modulating the intracellular Ca 2+ concentration homeostasis. Increasing evidence indicates that, in addition to its inimitable function in glucose metabolism, insulin plays critical roles in a variety of other physiological and pathological modulations, such as regulation of inflammatory response and nitric oxide production [1, 24, 25] . We have also previously demonstrated that insulin improves myocardial functions following I/R in an in vivo model [3] . However, the mechanism underlying these insulin-induced effects is unclear. In a recent study, we provided evidence that insulin exerts direct positive inotropic action on cardiomyocytes [4] . To further determine the effect of insulin on myocardium in I/R conditions in vitro, in our present study, ventricular myocytes isolated from adult rat were subjected to 15 min ischemia and subsequent 30 min reperfusion, during which the cells were field-stimulated and myocyte shortening/ relengthening and intracellular Ca 2+ transients were simultaneously observed.
Considering the cardiac myocyte is composed of bundles of myofibrils that contain sarcomeres representing the basic contractile units of the myocyte and related to the intracellular free Ca 2+ concentration ([Ca 2+ ] i ), we reflected the cardiomyocyte contractile function with the change of the myocyte sarcomere length. It was seen that simulated ischemia by chemical anoxia solution decreased the amplitude of contraction to approximately 40% of the pre-ischemic level, which was restored, though not completely, to the pre-ischemic level by reperfusion with Tyrode's solution. Interestingly, treatment with insulin (10 -7 mol/L) at the onset of reperfusion significantly enhanced the recovery of contractile function as evidenced by increased PTA and ±dL/dt and shortened TPS and TR70 in I/R cardiomyocytes, compared with those in cells reperfused with vehicle (Table 1) . Concomitantly, the intracellular Ca 2+ transients (Ca 2+ fluorescence ratio, ∆FFI) induced by field-stimulation was restored to the pre-ischemic level by reperfusion with vehicle in simulated I/R myocytes. As the amplitude of Ca 2+ transients was increased, and TTPCa and T 50 DCa were overtly reduced by insulin treatment in I/R myocytes ( [26, 27] . A dysfunction of SERCA2a has been proposed as a contributing factor to the development of cardiovascular diseases in which cytokines are involved, such as genetic hypertension, I/R injury, myocardial stunning, and heart failure [28] . However, SERCA2a overexpression in cardiomyocytes from the left ventricle of patients with HF can restore normal Ca 2+ cycling [6] . In the present study, to determine the role of SERCA2a in the insulin-induced alteration of Ca 2+ transients, we measured SERCA2a activity in myocytes. No remarkable change was observed in myocytes undergoing simulated I/R procedure, which is different from some previous data that SERCA2a expression and activity decreased with increasing severity of HF after MI [10] . The difference might be due to the shorter time-course of I/R in vitro in this study. In contrast, we found that treatment with insulin significantly increased SERCA2a activity compared with vehicle reperfusion, suggesting that increased SERCA2a activity might contribute to the improvement of intracellular Ca 2+ transients and subsequent contraction by insulin in I/R myocytes.
We have demonstrated that insulin exerts anti-apoptotic effects in both cardiomyocytes and coronary endothelial cells following I/R by Akt-eNOS signal in vivo, that is, the survival signaling pathway, which might further contribute to the prolonged improvement of cardiac function after reperfusion [1] [2] [3] . In addition, it was also shown in our previous study that insulin has a direct positive inotropic effect on isolated cardiomyocytes by activating Akt. This is consistent with the notion that transgenic overexpression of Akt enhances myocyte contractility and relaxation through acceleration of intracellular Ca 2+ transients in mice [11] . However, the direct link between Akt activation and improvement of myocyte contraction by insulin remains largely unclear. In the present study, we found that insulin resulted in a 2.9-fold increase in phosphorylation of Akt in I/R myocytes, which was inhibited by pretreatment of the cells with a specific AI. Most importantly, inhibition of Akt activity with AI also significantly abolished increased SERCA activity, Ca 2+ transients and contractile activity by insulin simultaneously in I/R myocytes. These data suggest that Akt is probably involved in the effects of insulin on SERCA2a, intracellular Ca 2+ handling and subsequent contractile function in I/R cardiomyocytes.
In summary, the present study demonstrated that insulin improves the recovery of contractile function in simulated I/ R cardiomyocytes in an Akt-dependent and SERCA2a-mediated fashion. This finding suggests that the insulin-activated Akt survival signaling not only contributes to the previously observed cardiac protective effects, but also plays a causative role in the direct inotropic action induced by insulin in I/R myocardium.
